Telegram | Placera.se

måndag 1 junimån 1 juni

Kontakta oss

redaktionen@placera.se

Frågor om forumet

support@placera.se

Tjänster

Redeye
SME Direkt
Investtech

Annonsera

Marc Lindh
annons@placera.se
073 855 81 42

Ansvarig utgivare

Peter Benson

Mer

Om Placera
Till Avanza
RSS
Personuppgifter
Användarvillkor

Box 1399, 111 93 Stockholm

OMX Stockholm 30

0,45%

(vid stängning)

Idag, 08:00

K2A utökar sin externa förvaltning

Idag, 07:09

Embracing a Zero-Carbon Future | The 6th LiuGong Global Customer Day Held in Liuzhou

Idag, 07:00

Supermicro Launches New Server Solutions with Intel Xeon 6+ Processors to Reduce TCO and Accelerate Time-to-Online for Large-Scale Cloud and Data Centers

Idag, 05:30

LG Display to showcase world's largest Gaming OLED lineup in Taiwan

Idag, 04:15

Long-term Follow-up Results of CARsgen's Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meeting

Idag, 02:00

Cango Inc. Reports First Quarter 2026 Unaudited Financial Results

Idag, 01:03

Preliminary Unaudited Financial Results for the Year Ended 31 March 2026

Idag, 01:00

edyoutec AB: Delårsrapport för perioden 1 Januari till 31 mars 2026

Idag, 00:30

Berkshire Hathaway to Acquire Taylor Morrison Home Corporation for $8.5 Billion

Igår, 22:29

UGRO: urban-gro, Inc. (Nasdaq: UGRO) Announces Lanka Premier League Season 6 Player Auction Set for June 1, 2026 @ 5:00 AM EDT (2:30 PM Colombo Time)

Igår, 22:00

ACED: Minutes of the Annual General Meeting 2026

Igår, 21:31

EQT sets target fund size for EQT Infrastructure VII at EUR 21 billion

Igår, 21:31

EQT fastställer mål för EQT Infrastructure VII till EUR 21 miljarder

Igår, 20:03

iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo

Igår, 18:30

AIK Fotboll har inlett förhandlingar

Canadian Pacific Kansas City

Igår, 18:18

CPKC to maintain rail operations across Canada during IBEW strike

Igår, 18:04

KALDVIK AS (KLDVK): Q1 2026 Quarterly Update

Igår, 17:00

HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO 2026 Plenary Session

Johnson & Johnson

Igår, 16:29

RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited

Johnson & Johnson

Igår, 16:27

Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradigm

AAC Clyde Space

Igår, 16:16

AAC Clyde Space receives EUR 7.6 M order for power and data handling systems for EPS-Sterna satellites

Igår, 16:01

Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer

Igår, 16:00

GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting

Igår, 16:00

Pfizer’s BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

Igår, 14:00

Magle Chemoswed Holding Reports Financial Results For First Quarter 2026

Igår, 14:00

Nokia Corporation - Managers' transactions (Hanrahan)

Igår, 12:35

Calligo publishes its interim report for Q1 2026.

Igår, 11:00

GreenMobility - Transactions by persons discharging managerial responsibilities and persons closely associated with them

Igår, 09:15

Pluvicto™ demonstrated consistent efficacy across key patient subgroups in metastatic hormone-sensitive prostate cancer

Six Flags Entertainment

Igår, 06:15

SIX FLAGS FIESTA TEXAS UNLEASHES WEREWOLF GORGE, THE WORLD'S LONGEST FAMILY LAUNCH ROLLER COASTER

Igår, 04:09

Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026

Igår, 04:00

Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet

Igår, 03:55

PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit

Igår, 02:36

STLA Deadline: STLA Investors with Losses in Excess of $100K Have Opportunity to Lead Stellantis N.V. Securities Fraud Lawsuit

Igår, 02:15

Take Your Shot & Make Your Moment: OPPO Ignites Football Culture with Technology at the UEFA Champions League Final

Igår, 01:31

SES AI Corporation Deadline: SES Investors with Losses in Excess of $100K Have Opportunity to Lead SES AI Corporation Securities Fraud Lawsuit Filed by The Rosen Law Firm

Igår, 01:24

ASCO 2026: Bayer Shares New Findings for NUBEQA® (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial

New Era Energy & Digital

Igår, 01:07

NUAI Deadline: NUAI Investors with Losses in Excess of $100K Have Opportunity to Lead New Era Energy & Digital, Inc. Securities Fraud Lawsuit

30 maj, 22:30

Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years

30 maj, 22:30

Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours

30 maj, 21:35

THE KILLERS ROCK THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®

30 maj, 19:55

Vertiseit announces outcome of TO 5A warrant exercise and receives SEK 13 million

30 maj, 19:55

Vertiseit offentliggör utfall av teckningsoptionsprogram TO 5A och tillförs 13 MSEK

30 maj, 19:40

BW LPG enters into agreement for eight 90’cbm Panamax newbuildings with Hyundai Heavy Industries

30 maj, 19:35

/C O R R E C T I O N -- Hyundai Motor America/

30 maj, 19:10

MakerWorld's First User-Initiated Charity Contest Names Winners, Bringing Global Creators' Goodwill Directly to Cancer Wards

30 maj, 17:57

GOSS 2-DAY DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS

ILIJA GREEN 001

30 maj, 16:30

Rapport Q1 2026 för Ilija Batljan Invest AB (publ)

30 maj, 16:00

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

30 maj, 16:00

GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting